CHFR Antibody

Code CSB-PA839315LA01HU
Size US$166
Order now
Image
  • Western Blot
    Positive WB detected in: HepG2 whole cell lysate, Hela whole cell lysate, Jurkat whole cell lysate, Mouse heart tissue
    All lanes: CHFR antibody at 3.2μg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000000 dilution
    Predicted band size: 74, 73, 70, 64 kDa
    Observed band size: 74 kDa

  • Immunohistochemistry of paraffin-embedded human endometrial cancer using CSB-PA839315LA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human lung cancer using CSB-PA839315LA01HU at dilution of 1:100

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) CHFR Polyclonal antibody
Uniprot No.
Target Names
CHFR
Alternative Names
Checkpoint with forkhead and ring finger domains antibody; Checkpoint with forkhead and RING finger domains protein antibody; Chfr antibody; CHFR_HUMAN antibody; E3 ubiquitin protein ligase CHFR antibody; E3 ubiquitin-protein ligase CHFR antibody; EC 6.3.2. antibody; FLJ10796 antibody; FLJ33629 antibody; RING finger protein 196 antibody; RNF 116 antibody; RNF 196 antibody; RNF116 antibody; RNF196 antibody; Ubiquitin ligase protein antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse
Immunogen
Recombinant Human E3 ubiquitin-protein ligase CHFR protein (141-422AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The CHFR Antibody (Product code: CSB-PA839315LA01HU) is Non-conjugated. For CHFR Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA839315LB01HU CHFR Antibody, HRP conjugated ELISA
FITC CSB-PA839315LC01HU CHFR Antibody, FITC conjugated
Biotin CSB-PA839315LD01HU CHFR Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC
Recommended Dilution
Application Recommended Dilution
WB 1:1000-1:5000
IHC 1:20-1:200
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
E3 ubiquitin-protein ligase that functions in the antephase checkpoint by actively delaying passage into mitosis in response to microtubule poisons. Acts in early prophase before chromosome condensation, when the centrosome move apart from each other along the periphery of the nucleus. Probably involved in signaling the presence of mitotic stress caused by microtubule poisons by mediating the 'Lys-48'-linked ubiquitination of target proteins, leading to their degradation by the proteasome. Promotes the ubiquitination and subsequent degradation of AURKA and PLK1. Probably acts as a tumor suppressor, possibly by mediating the polyubiquitination of HDAC1, leading to its degradation. May also promote the formation of 'Lys-63'-linked polyubiquitin chains and functions with the specific ubiquitin-conjugating UBC13-MMS2 (UBE2N-UBE2V2) heterodimer. Substrates that are polyubiquitinated at 'Lys-63' are usually not targeted for degradation, but are rather involved in signaling cellular stress.
Gene References into Functions
  1. JNK inhibitor prevents SIRT1 phosphorylation, leading to elevated SIRT1 protein levels even in the presence of H2O2. Taken together, our results indicate that CHFR plays a crucial role in the cellular stress response pathway by controlling the stability and function of SIRT1. PMID: 27883020
  2. Re-expression of CHFR in miR-26a overexpressing cells partially rescues normal mitosis and impairs the tumorigenesis exerted by miR-26a. PMID: 28126920
  3. Data show that hypermethylation of the CHFR promoter, frequent in acute myeloid leukemia, is associated with adverse outcome, and can thus be used for risk stratification. PMID: 26542416
  4. Small molecule inhibition of CHFR-PARP1 interaction is a novel potential therapeutic approach to increase the efficacy of taxane-based chemotherapy in cancer. PMID: 26356822
  5. CHFR unmethylation is associated with oxaliplatin resistance in gastric cancer. PMID: 24748501
  6. CHFR methylation has a role in methylation of DNA damage repair and apoptotic pathway genes in non-small cell lung cancer PMID: 25828518
  7. CHFR promoter methylation is associated with colorectal cancer. PMID: 24928946
  8. CHFR-PAX5 fusion transcript is associated with B-cell precursor acute lymphoblastic leukemia. PMID: 25304615
  9. Aberrant methylation of CHFR may be associated with the pathogenesis, progression for B-cell non-Hodgkin lymphoma(B-NHL), which might be a novel molecular marker as prognosis and treatment for B-NHL. PMID: 25798877
  10. Studies indicate that checkpoint with forkhead and ring finger domains (CHFR) promoter CpG island methylation as prognostic marker. PMID: 24375389
  11. CHFR ubiquitinates and regulates TOPK levels, which is essential for its checkpoint function. PMID: 24012691
  12. CHFR methylation may have a role in chemosensitivity of paclitaxel in advanced gastric cancer PMID: 24639283
  13. CHFR methylation in CRC cell lines predicted for sensitivity in vitro and in vivo to docetaxel, while MSI-H cell lines were more sensitive to gemcitabine PMID: 23873170
  14. CHFR expression is a novel predictive marker of response and overall survival in NSCLC patients treated with taxane-containing chemotherapy PMID: 23386692
  15. CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes. PMID: 23415374
  16. a new regulatory mechanism for CHFR that sequential post-translational modifications of CHFR by SUMO and ubiquitin coordinately regulates its stability PMID: 23454125
  17. this study underscores the importance of CHFR SUMOylation as a new regulatory mechanism of CHFR and highlights the emerging role of SUMOylation in modulating protein stability. PMID: 23131550
  18. Aggregated LDL prolongs the half life of LRP1 by preventing the receptor ubiquitinylation, at least in part, through CHFR targeting. PMID: 23241409
  19. suppression of CHFR induced a significant increase of the mitotic index and much lower numbers of cells at the G2/M phase in both cells treated with taxol, indicating mitotic checkpoint impairment PMID: 22469813
  20. CHFR is thought to contribute towards regulating mitotic entry and possible explanations for contradictory observations published on the functions and regulation of CHFR are presented. [review] PMID: 22159584
  21. The interaction between CHFR and PARP-1 plays an important role in cell cycle regulation and cancer therapeutic strategies. PMID: 22337872
  22. CHFR is epigenetically inactivated by promoter methylation in nasopharyngeal carcinoma. PMID: 22070084
  23. Hypermethylation of CHFR gene is associated with advanced gastric cancer. PMID: 21409489
  24. Aberrant methylation of the CHFR gene is a frequent event in the carcinogenesis of gastric cancer. PMID: 20109344
  25. The extent of CHFR promoter methylation correlates with RFS, indicating it is a promising epigenetic marker for recurrence. PMID: 21551253
  26. auto-ubiquitylation of E3 ubiquitin-protein ligase Chfr at G2 phase is required for accumulation of polo-like kinase 1 and mitotic entry in mammalian cell PMID: 21768102
  27. Aberrant promoter methylation of Runx3 and CHFR genes may be involved in the carcinogenesis and development of gastric cancer PMID: 20300977
  28. Hypermethylation of CHFR gene promoter is associated with loss or lower expression of CHFR mRNA in laryngeal squamous cell carcinoma. PMID: 20942233
  29. These data support a critical role for CHFR in the MAD2 spindle checkpoint. PMID: 21575600
  30. CHFR methylation in cancer tissues was significantly associated with the extent of differentiation and lymph node metastasis of gastric cancer. PMID: 21302620
  31. results demonstrate that CHFR loss might be critical for the tumorigenesis of NSCLC in patients with a history of smoking and induces tumors of a more malignant phenotype than the EGFR mutation PMID: 20473935
  32. The PBZ motif of CHFR recognizes two adenine-containing subunits of PAR and the phosphate backbone that connects them PMID: 20880844
  33. Taken together, their findings demonstrated that both epigenetic and genetic mechanisms were involved in silencing CHFR expression in EACs. PMID: 20564104
  34. The Chfr-TCTP interaction was stable throughout the cell cycle, but it could be diminished by the complete depolymerization of the microtubules. PMID: 18504434
  35. this is the first report identifying the regulatory mechanism of HLTF by CHFR, suggesting that CHFR-mediated downregulation of HLTF may help protect against cancer. PMID: 20388495
  36. Gene methylation (CHFR, E-cadherin, BNIP3) in the peritoneal fluid could detect occult neoplastic cells in the peritoneum and might be a risk factor for peritoneal metastasis. PMID: 20082478
  37. checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition PMID: 11807090
  38. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. PMID: 11912157
  39. expression is downregulated by CpG island hypermethylation in esophageal cancer PMID: 12376479
  40. Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer. PMID: 12538348
  41. CHFR has a role in mitotic checkpoint control PMID: 12810945
  42. Chfr may have a role in signaling the presence of mitotic stress induced by microtubule poisons PMID: 14562038
  43. That the chfr gene is frequently silenced in various tumors because of methylation of its promoter, these findings suggest that chfr is inactivated by multiple mechanisms in human cancer. PMID: 14612512
  44. Chfr is frequently inactivated in colon but not breast cancers, through a mechanism of hypermethylation of the promoter sequences. PMID: 14654793
  45. Aberrant promoter methylation of the CHFR gene was observed in a significant proportion of human gastric cancers. PMID: 15201973
  46. CHFR has a role in blocking mitosis along with p38 MAP kinase PMID: 15302856
  47. PML bodies control the distribution, dynamics and function of CHFR PMID: 15467728
  48. We conclude that the mechanism by which CHFR delays chromosome condensation involves inhibition of accumulation of Cyclin B1 in the nucleus. PMID: 15674323
  49. The loss of checkpoint control associated with methylation of CHFR suggests the potential to overcome cell cycle checkpoints, which may lead to an accumulation of mutations. PMID: 15760919
  50. downregulation of CHFR is a common event in nasopharyngeal carcinoma cells which may be due to hypermethylation of the gene promoter region PMID: 15937956

Show More

Hide All

Subcellular Location
Nucleus, PML body.
Protein Families
CHFR family
Tissue Specificity
Ubiquitous.
Database Links

HGNC: 20455

OMIM: 605209

KEGG: hsa:55743

STRING: 9606.ENSP00000392395

UniGene: Hs.720197

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*